Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.

Laud, K; Marian, C; Avril, M F; Barrois, M; Chompret, A; Goldstein, A M; Tucker, M A; Clark, P A; Peters, G; Chaudru, V; Demenais, F; Spatz, A; Smith, M W; Lenoir, G M; Bressac-de Paillerets, B

Laud, K; Marian, C; Avril, M F; Barrois, M; Chompret, A; Goldstein, A M; Tucker, M A; Clark, P A; Peters, G; Chaudru, V; Demenais, F; Spatz, A; Smith, M W; Lenoir, G M; Bressac-de Paillerets, B.

Affiliation

Laud K; Service de Génétique, Institut Gustave Roussy, 94800 Villejuif, France.

J Med Genet ; 43(1): 39-47, 2006 Jan.

Article in En | MEDLINE | ID: mdl-15937071

Subject(s)

Cyclin-Dependent Kinase Inhibitor p15/genetics; Melanoma/genetics; Tumor Suppressor Protein p14ARF/genetics; Cell Line, Tumor; Chromosomes, Human, Pair 9/genetics; DNA Mutational Analysis; Exons/genetics; Gene Deletion; Genes, Neoplasm; Genetic Linkage; Germ-Line Mutation/genetics; Humans; Mutation, Missense/genetics; Pedigree; RNA, Messenger/genetics; RNA, Messenger/metabolism; RNA, Untranslated/genetics; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p14ARF / Cyclin-Dependent Kinase Inhibitor p15 / Melanoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Med Genet Year: 2006 Document type: Article

Fulltext

XML

PubMed Links

Search on Google